Mark Stephen Etherington, MD
Assistant Professor of Surgery at the Hospital of the University of Pennsylvania
Active Surgeon, Penn Presbyterian Medical Center, Philadelphia, PA
Active Surgeon, Cpl. Michael J. Crescenz Veterans Affair Medical Center, Philadelphia, PA
Active Surgeon, Pennsylvania Hospital, Philadelphia, PA
Attending Surgeon, Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Surgery
Contact information
Division of Endocrine & Oncologic Surgery
Penn Medicine Washington Square
800 Walnut Street, 20th Floor
Philadelphia, PA 19107
Penn Medicine Washington Square
800 Walnut Street, 20th Floor
Philadelphia, PA 19107
Office: 215-614-1963
Education:
BA (Neuroscience)
Vanderbilt University, Nashville, TN, 2011.
MD
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 2015.
Permanent linkBA (Neuroscience)
Vanderbilt University, Nashville, TN, 2011.
MD
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 2015.
Selected Publications
Etherington MS, Geller DA: Minimally invasive vs. open liver resections for hepatocellular carcinoma and colorectal cancer liver metastases. Surgery: Evidence Based Practice, 2d Edition. Brower ST, Cohn SM (eds.). New Haven, CT: PMPH-USA, 2024 (in press).Etherington MS, Handzel R, Ongchin M, Choudry MH, Tohme ST, Paniccia A, Lee KK, Zureikat A, Geller DA: Remnant completion cholecystectomy is on the rise: Don't three-putt it. HPB (Oxford) 26(8): 1072-1074, Aug. 2024 Notes: Epub Apr. 23, 2024.
Etherington MS, O’Sullivan R, Paniccia A, Brand RE, McGrath K, Slivka A, Singhi AD, Zureikat AH: Genomic profiling of pancreatic neuroendocrine tumors defines clinically relevant prognostic markers. HPB 26(2): S613-S614, Apr. 2024 Notes: Oral presentation at the Americas Hepato-Pancreato-Biliary Association 2024 Annual Meeting, Miami Beach, FL, Apr. 2024.
Etherington MS, Handzel R, Ongchin M, Choudry MH, Tohme ST, Paniccia A, Lee KK, Zureikat A, Geller DA: Remnant cholecystectomy: A twenty year institutional experience. HPB 26(2): S645, Apr. 2024 Notes: Oral presentation at the Americas Hepato-Pancreato-Biliary Association 2024 Annual Meeting, Miami Beach, FL, Apr. 2024.
Wach MM, Washburn LA, Alvikas J, Qu LT, Zhang M, Etherington MS, Rieser C, Haykal T, Pingpank JF, Zureikat AH, Geller DA, Hoehn RS, Tohme S: Combined hepatic resection and ablation for high burden of colorectal liver metastases demonstrates safety and durable survival. HPB (Oxford) 26(3): 362-369, Mar. 2024 Notes: Epub Nov. 10, 2023.
Lo WM, Dogeas E, Etherington MS, Ferrone C, Nebbia M, Cleary S, Pery R, Steel JL, Tohme ST, Geller DA: Long-term overall survival in patients undergoing liver resection for metastatic anal squamous cell carcinoma. Journal of Surgical Oncology 129(3): 568-573, Mar. 2024 Notes: Epub Nov. 29, 2023.
Etherington MS, Hanna AN, Medina BD, Liu M, Tieniber AD, Kwak HV, Tardy KJ, Levin L, Do KJ, Rossi F, Zeng S, DeMatteo RP: Tyrosine kinase inhibition activates intratumoral gamma delta T cells in gastrointestinal stromal tumor. Cancer Immunology Research 12(1): 107-119, Jan. 3 2024.
Etherington MS, Tohme ST, Ongchin M, Geller DA: Remnant completion cholecystectomy at a single institution over 20 years: Don't three-putt it. Journal of the American College of Surgeons 23(5 Suppl 1): S301-S302, Nov. 2023 Notes: Presented at the 9th Owen H Wangensteen Scientific Forum of the American College of Surgeons Clinical Congress, Boston, MA, Oct. 2023.
Tieniber AD, Rossi F, Hanna AN, Liu M, Etherington MS, Loo JK, Param N, Zeng S, Do K, Wang L, DeMatteo RP: Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor. Oncogene 42(34): 2578-2588, Aug. 2023 Notes: Epub July 19, 2023.
Rossi F, Liu M, Tieniber A, Etherington MS, Hanna A, Vitiello GA, Param NJ, Do K, Wang L, Antonescu CR, Zeng S, Zhang JQ, DeMatteo RP: Myosin light-chain kinase inhibition potentiates the antitumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor. Clinical Cancer Research 29(11): 2144-2157, June 1 2023.